Erin F. Blau
Erin F. Blau has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Abena Asamoa-Amoakohene
Ghana Food and Drugs Authority, Accra, Ghana
1 shared publicationAlexander Dodoo
African Collaborating Centre for Pharmacovigilance and Surveillance, Accra, Ghana
1 shared publicationAllison Napier
Montgomery Cty Hlth Dept, Mt Sterling, KY USA
1 shared publicationAndrea Flinchum
Kentucky Cabinet Hlth & Family Serv, Dept Publ Hlth, Frankfort, KY 40621 USA
1 shared publication- Anna Shaum
Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, USA
1 shared publication Anne M. Hause
CDC, Natl Ctr Emerging Zoonot & Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA
1 shared publication
Latest Publications
- Open Access
- 5 November 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (5) , 945-949
Strengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring
: Enhancing surveillance for adverse events following immunization remains a key global immunization priority. Many low- and middle-income countries (LMICs) are implementing new vaccines without the comprehensive safety monitoring typically conducted in high-income countries. Since 2017, the Global Immunization Safety Team at the US Centers for Disease Control and Prevention, in collaboration with partners, has supported establishing sentinel surveillance systems during vaccine introductions for safety monitoring in LMICs. Through these experiences, many lessons have been learned regarding project initiation, funding opportunities, standardizing data collection, background rate challenges, site selection considerations, and partner coordination. If vaccine safety is prioritized, sentinel surveillance enhances routine monitoring and generates valuable safety data, strengthening the immunization and regulatory programs. As many countries introduce and manufacture vaccines not previously monitored in high-income countries, lessons from safety monitoring during earlier vaccine introductions must be applied. Sustaining the gains in immunization that were hard-earned over the past decades depends on it.
- 5 November 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (5) , 945-949
Open AccessStrengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring
: Enhancing surveillance for adverse events following immunization remains a key global immunization priority. Many low- and middle-income countries (LMICs) are implementing new vaccines without the comprehensive safety monitoring typically conducted in high-income countries. Since 2017, the Global Immunization Safety Team at the US Centers for Disease Control and Prevention, in collaboration with partners, has supported establishing sentinel surveillance systems during vaccine introductions for safety monitoring in LMICs. Through these experiences, many lessons have been learned regarding project initiation, funding opportunities, standardizing data collection, background rate challenges, site selection considerations, and partner coordination. If vaccine safety is prioritized, sentinel surveillance enhances routine monitoring and generates valuable safety data, strengthening the immunization and regulatory programs. As many countries introduce and manufacture vaccines not previously monitored in high-income countries, lessons from safety monitoring during earlier vaccine introductions must be applied. Sustaining the gains in immunization that were hard-earned over the past decades depends on it.
- Open Access
- 8 December 2023
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 72 (49) , 1321-1326
Progress in Immunization Safety Monitoring — Worldwide, 2020–2022
This report describes progress in the use of the immunization safety monitoring indicator and progress on joint adverse events following immunization among World Health Organization-affiliated countries and territories.
- 8 December 2023
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 72 (49) , 1321-1326
Open AccessProgress in Immunization Safety Monitoring — Worldwide, 2020–2022
This report describes progress in the use of the immunization safety monitoring indicator and progress on joint adverse events following immunization among World Health Organization-affiliated countries and territories.
- Open Access
- 22 October 2021
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 70 (42) , 1472-1477
Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations — Indiana, Kentucky, and Ohio, September 2018–February 2019
This report describes a 2018 investigation of Myobacterium porcinum skin infections among people who received vaccinations.
- 22 October 2021
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 70 (42) , 1472-1477
Open AccessMycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations — Indiana, Kentucky, and Ohio, September 2018–February 2019
This report describes a 2018 investigation of Myobacterium porcinum skin infections among people who received vaccinations.